NKX2-1-AS1: A Drug Target / Disease Biomarker (G100506237)
NKX2-1-AS1: A Drug Target / Disease Biomarker
The protein NKX2-1-AS1 is a potential drug target or biomarker that has been identified in various scientific studies. NKX2-1-AS1 is a non-key protein, which means it does not have any known functions in the body. However, it is found in many organisms, including humans, and is involved in various cellular processes.
One of the main functions of NKX2-1-AS1 is its role in the immune system. NKX2-1-AS1 is a member of the NKX2 family of proteins, which are involved in the regulation of cell death and apoptosis. These proteins are known for their ability to induce apoptosis in cancer cells, which can be an effective way to target cancer tumors.
In addition to its role in the immune system, NKX2-1-AS1 has also been shown to be involved in the regulation of cell growth and differentiation. NKX2-1-AS1 has been shown to promote the growth and survival of cancer cells, which suggests that it may be a potential drug target for cancer therapies.
The potential drug target status of NKX2-1-AS1 is supported by several scientific studies. For example, a study published in the journal Oncogene found that NKX2-1-AS1 was highly expressed in human cancer tissues and was associated with poor prognosis in cancer patients. Another study published in the journal PLoS One found that NKX2-1-AS1 was overexpressed in human breast cancer tissues and was associated with the development of cancer-related metastasis.
In addition to its potential drug target and biomarker properties, NKX2-1-AS1 also has potential as a diagnostic tool. The lack of known functions of NKX2-1-AS1 makes it difficult to use it as a specific biomarker for any particular disease. However, its potential role in the immune system and cell growth regulation suggests that NKX2-1-AS1 may be a useful marker for tracking disease progression and evaluating the effectiveness of potential therapies.
Overall, the protein NKX2-1-AS1 is a promising drug target or biomarker with potential for the development of cancer therapies. Further research is needed to fully understand its functions and potential uses in the immune system and healthcare.
Protein Name: NKX2-1 Antisense RNA 1
The "NKX2-1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NKX2-1-AS1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
NKX2-2 | NKX2-3 | NKX2-4 | NKX2-5 | NKX2-6 | NKX2-8 | NKX3-1 | NKX3-2 | NKX6-1 | NKX6-2 | NKX6-3 | NLE1 | NLGN1 | NLGN1-AS1 | NLGN2 | NLGN3 | NLGN4X | NLGN4Y | NLK | NLN | NLRC3 | NLRC4 | NLRC4 Inflammasome | NLRC5 | NLRP1 | NLRP1 Inflammasome | NLRP10 | NLRP11 | NLRP12 | NLRP13 | NLRP14 | NLRP2 | NLRP2B | NLRP3 | NLRP3 Inflammasome | NLRP3P1 | NLRP4 | NLRP5 | NLRP6 | NLRP7 | NLRP8 | NLRP9 | NLRP9P1 | NLRX1 | NMB | NMBR | NMD3 | NMDA receptor | NME1 | NME1-NME2 | NME2 | NME2P1 | NME3 | NME4 | NME5 | NME6 | NME7 | NME8 | NME9 | NMI | NMNAT1 | NMNAT2 | NMNAT3 | NMRAL1 | NMRAL2P | NMRK1 | NMRK2 | NMS | NMT1 | NMT2 | NMTRQ-TTG10-1 | NMTRQ-TTG12-1 | NMTRV-TAC1-1 | NMU | NMUR1 | NMUR2 | NNAT | NNMT | NNT | NNT-AS1 | NOA1 | NOB1 | NOBOX | NOC2L | NOC2LP2 | NOC3L | NOC4L | NOCT | NOD1 | NOD2 | NODAL | NOG | NOL10 | NOL11 | NOL12 | NOL3 | NOL4 | NOL4L | NOL4L-DT | NOL6
